{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:55:10Z","timestamp":1789620910063,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006318","name":"University Carlos III of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015883","name":"Sociedad Espa\u00f1ola de Nefrolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI22\/01673"],"award-info":[{"award-number":["PI22\/01673"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/01510"],"award-info":[{"award-number":["PI24\/01510"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT23\/00078"],"award-info":[{"award-number":["INT23\/00078"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ERA-PerMed-JTC 2022 (ONAKI-ICI AC22\/00029"],"award-info":[{"award-number":["ERA-PerMed-JTC 2022 (ONAKI-ICI AC22\/00029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD24\/0004\/0031"],"award-info":[{"award-number":["RD24\/0004\/0031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0016"],"award-info":[{"award-number":["RD21\/0005\/0016"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01292"],"award-info":[{"award-number":["PI21\/01292"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.kint.2025.06.013","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:23:09Z","timestamp":1751581389000},"page":"572-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification"],"prefix":"10.1016","volume":"108","author":[{"given":"Jorge","family":"Rico-Fontalvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Ciudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"D\u00edaz-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Lecube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Daza-Arnedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5824-6973","authenticated-orcid":false,"given":"Enrique","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-1929","authenticated-orcid":false,"given":"Borja","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Porrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente S\u00e1nchez","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Toniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-0766","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.06.013_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1209245","article-title":"Assessment of obesity stigma and discrimination among Spanish subjects with a wide weight range: the OBESTIGMA study","volume":"14","author":"S\u00e1nchez","year":"2023","journal-title":"Front Psychol"},{"key":"10.1016\/j.kint.2025.06.013_bib2","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"issue":"360","key":"10.1016\/j.kint.2025.06.013_bib3","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.kint.2025.06.013_bib5","first-page":"1","article-title":"The Spanish GIRO guideline: a paradigm shift in the management of obesity in adults","author":"Lecube","year":"2025","journal-title":"Obes Facts"},{"key":"10.1016\/j.kint.2025.06.013_bib6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41366-020-0548-0","article-title":"Obesity and cardiovascular disease in women","volume":"44","author":"Manrique-Acevedo","year":"2020","journal-title":"Int J Obes (2005)"},{"key":"10.1016\/j.kint.2025.06.013_bib7","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.06.013_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(23)00058-X","article-title":"Lancet Diabetes & Endocrinology Commission on the definition and diagnosis of clinical obesity","volume":"11","author":"Rubino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.06.013_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: an emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D\u2019Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.56867\/32","article-title":"Obesidad y enfermedad renal cr\u00f3nica: una mirada desde los mecanismos fisiopatol\u00f3gicos: revisi\u00f3n narrativa","volume":"10","author":"Rico-Fontalvo","year":"2022","journal-title":"Revista Sociedad Ecuatoriana Nefrolog\u00eda Di\u00e1lisis Trasplante"},{"key":"10.1016\/j.kint.2025.06.013_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.655871","article-title":"A nephrologist perspective on obesity: from kidney injury to clinical management","volume":"8","author":"Garc\u00eda-Carro","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.kint.2025.06.013_bib13","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.kint.2025.06.013_bib14","doi-asserted-by":"crossref","first-page":"E871","DOI":"10.1152\/ajpendo.00135.2019","article-title":"Renal hemodynamics and fatty acid uptake: effects of obesity and weight loss","volume":"317","author":"Rebelos","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.kint.2025.06.013_bib15","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.ekir.2023.08.011","article-title":"Obesity weight loss phenotypes in CKD: measured GFR and albumin-to-creatinine excretion ratio place for stratification","volume":"8","author":"Rico-Fontalvo","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.06.013_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology","volume":"49","author":"Brenner","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/dc11-2189","article-title":"Glomerular hyperfiltration and renal disease progression in type 2 diabetes","volume":"35","author":"Ruggenenti","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.06.013_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00394-015-0923-0","article-title":"Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes","volume":"55","author":"Ogna","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.kint.2025.06.013_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.ki.5001729","article-title":"Time to abandon microalbuminuria?","volume":"70","author":"Ruggenenti","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1681\/ASN.2014010115","article-title":"Renal hyperfiltration as a novel marker of all-cause mortality","volume":"26","author":"Park","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41366-019-0476-z","article-title":"The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors","volume":"44","author":"L\u00f3pez-Mart\u00ednez","year":"2020","journal-title":"Int J Obes (2005)"},{"key":"10.1016\/j.kint.2025.06.013_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ndt\/gfac254","article-title":"What should European nephrology do with the new CKD-EPI equation?","volume":"38","author":"Gansevoort","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.06.013_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000499486","article-title":"Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity","volume":"143","author":"Chagnac","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2025.06.013_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101420","article-title":"Early life body mass index trajectories and albuminuria in midlife: a 30-year prospective cohort study","volume":"48","author":"Wang","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.kint.2025.06.013_bib25","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.3390\/nu13124482","article-title":"Impact of obesity in kidney diseases","volume":"13","author":"Kotsis","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2025.06.013_bib26","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1681\/ASN.2010090969","article-title":"ACE inhibition is renoprotective among obese patients with proteinuria","volume":"22","author":"Mallamaci","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41591-024-03327-6","article-title":"Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial","volume":"31","author":"Apperloo","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.06.013_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.06.013_bib29","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.06.013_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.kint.2018.11.026","article-title":"The spectrum of kidney biopsy findings in patients with morbid obesity","volume":"95","author":"Choung","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13450","article-title":"Obesity-related glomerulopathy: current approaches and future perspectives","volume":"23","author":"Mart\u00ednez-Montoro","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/j.kint.2025.06.013_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.06.013_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2024.11.013","article-title":"Kidney and cardiovascular outcomes among patients with CKD receiving GLP-1 receptor agonists: a systematic review and meta-analysis of randomized trials","volume":"85","author":"Chen","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2018.02.362","article-title":"Obesity, metabolic abnormality, and progression of CKD","volume":"72","author":"Yun","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2020.08.016","article-title":"Strategies to treat obesity in patients with CKD","volume":"77","author":"Chintam","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","article-title":"Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference","volume":"19","author":"Wan","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.kint.2025.06.013_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ckj\/sfaa162","article-title":"Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology","volume":"13","author":"Carriazo","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/00325481.2023.2216987","article-title":"The relationship between visceral adipose index and resistant hypertension in people living with diabetes","volume":"135","author":"G\u00f6kalp","year":"2023","journal-title":"Postgraduate Med"},{"key":"10.1016\/j.kint.2025.06.013_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ajh\/hpac091","article-title":"Relationship between risks for obstructive sleep apnea, resistant hypertension, and aldosterone among African American adults in the Jackson Heart Study","volume":"35","author":"Koo","year":"2022","journal-title":"Am J Hypertension"},{"key":"10.1016\/j.kint.2025.06.013_bib40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.ajkd.2022.04.005","article-title":"The risk of cardiovascular events in individuals with primary glomerular diseases","volume":"80","author":"Canney","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib41","article-title":"Association of obesity with the development of end stage renal disease in IgA nephropathy patients","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2025.06.013_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1164-2","article-title":"Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy","volume":"19","author":"Wu","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.semnephrol.2021.06.002","article-title":"The renal pathology of obesity: structure-function correlations","volume":"41","author":"Tsuboi","year":"2021","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.890900","article-title":"A mixed-method evaluation of the relationship between Oxford classification scores and longitudinal changes in proteinuria in patients with immunoglobulin A nephropathy","volume":"13","author":"Xu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2025.06.013_bib45","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1523-1755.1999.00389.x","article-title":"Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients","volume":"55","author":"Fleischmann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.ackd.2012.10.009","article-title":"Obesity in patients undergoing dialysis and kidney transplantation","volume":"20","author":"Friedman","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib47","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population","volume":"17","author":"Kramer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ckj\/sfab139","article-title":"The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years","volume":"15","author":"Than","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.56867\/41","article-title":"Mortalidad en pacientes con enfermedad renal cr\u00f3nica 5D asociada a la obesidad: una revisi\u00f3n narrativa","volume":"11","author":"Silva","year":"2023","journal-title":"Revista Sociedad Ecuatoriana Nefrolog\u00eda Di\u00e1lisis Trasplante"},{"key":"10.1016\/j.kint.2025.06.013_bib50","first-page":"44","article-title":"Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients","volume":"50","author":"Kaizu","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2022.880097","article-title":"Obesity, weight gain, and fluid overload in peritoneal dialysis","volume":"2","author":"Ng","year":"2022","journal-title":"Front Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241242","article-title":"Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients","volume":"15","author":"Chan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.06.013_bib53","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","article-title":"Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial","volume":"13","author":"Paniagua","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib54","article-title":"Impact of extremes of body mass index (BMI) in end-stage renal disease (ESRD) patients","volume":"14","author":"Rabbani","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.kint.2025.06.013_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.6002\/ect.2020.0074","article-title":"Obesity in living-donor kidney transplant: what risks for the donor and the recipient?","volume":"19","author":"Bentata","year":"2021","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.kint.2025.06.013_bib56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ajt.15626","article-title":"Robotic kidney transplantation in the obese patient: 10-year experience from a single center","volume":"20","author":"Tzvetanov","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2025.06.013_bib57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semnephrol.2021.03.013","article-title":"Obesity, chronic kidney disease, and kidney transplantation: an evolving relationship","volume":"41","author":"Azhar","year":"2021","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib58","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study","volume":"16","author":"S\u00e1nchez Fructuoso","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.925619","article-title":"Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management","volume":"9","author":"Stasi","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.kint.2025.06.013_bib60","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3390\/biomedicines11102785","article-title":"Impact of treatment with GLP1 receptor agonists, liraglutide 3.0 mg and semaglutide 1.0 mg, while on a waiting list for bariatric surgery","volume":"11","author":"Rubio-Herrera","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.kint.2025.06.013_bib61","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1681\/ASN.0000000512","article-title":"ASN kidney health guidance on the management of obesity in persons living with kidney diseases","volume":"35","author":"Ikizler","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s13679-023-00500-9","article-title":"The fat kidney","volume":"12","author":"Verde","year":"2023","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.kint.2025.06.013_bib63","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc12-1846","article-title":"Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial","volume":"36","author":"Tirosh","year":"2013","journal-title":"Diabetes Care"},{"issue":"4S","key":"10.1016\/j.kint.2025.06.013_bib64","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-016-0400-x","article-title":"Physical activity and metabolic health in chronic kidney disease: a cross-sectional study","volume":"17","author":"Bowlby","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.121.055459","article-title":"Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER","volume":"145","author":"Shaman","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.06.013_bib67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.06.013_bib68","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/jcm9040947","article-title":"GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists","volume":"9","author":"G\u00f3rriz","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.kint.2025.06.013_bib69","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc22-1889","article-title":"Effects of Semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.06.013_bib70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.06.013_bib71","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.06.013_bib72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ckj\/sfac274","article-title":"Tirzepatide and prevention of chronic kidney disease","volume":"16","author":"Bosch","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae039","article-title":"Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?","volume":"17","author":"Moreno-P\u00e9rez","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib74","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s11695-022-06091-z","article-title":"Effect of bariatric surgery on albuminuria in non-diabetic non-hypertensive patients with severe obesity: a short-term outcome","volume":"32","author":"Fathy","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/j.kint.2025.06.013_bib75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.06.013_bib76","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ckj\/sfaa266","article-title":"Renoprotective role of bariatric surgery in patients with established chronic kidney disease","volume":"14","author":"Morales","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.06.013_bib77","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.ajkd.2016.09.020","article-title":"Estimated GFR before and after bariatric surgery in CKD","volume":"69","author":"Imam","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.06.013_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-017-0474-0","article-title":"Effect of large weight reductions on measured and estimated kidney function","volume":"18","author":"Von Scholten","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.06.013_bib79","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825005058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825005058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:43:11Z","timestamp":1762231391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825005058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0085253825005058"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.06.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S.E.N., SLANH, and SEEDO consensus report on obesity-related kidney disease: proposal for a new classification","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}